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ABSTRACT 
The rapid progress in the pharmaceutical industry is due to the advancement in the digitalization and automation starting from the invention to the 
administration of the drug. Every advancement in the development of the pharmaceutical product is associated with progress in digitalization. A 
drug or a drug product to be administered safely and to provide efficacy it has to undergo a long journey from its discovery, including pre-clinical 
and clinical trials to further product development in the research and development. The production and manufacturing systems with appropriate 
digitalization and automation compile the drug formulation after the servitude of the research and development (RandD) department. Later, the 
quality control and quality assurance systems utilize digitalization to maintain the quality and standard of the drug product. Subsequently, 
packaging and labeling of the drug product are carried out with effective automation. Further, the marketing and supply of the drug products are 
digitally monitored and dispatched to the distributors and the pharmacies. Finally, the drug product will be dispensed to the patient for its 
administration with a concordance of digitally monitoring for enhanced efficacy and safety. Therefore, in this review article, various strategies for 
digitalization and automation in the pharmaceuticals from drug discovery to drug administration are briefly discussed.  
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The lifeblood of any industry is innovation, the discovery and 
development of new medicines are worked out with unique 
challenges, ethical implications and social responsibilities also the 
process seems arcane. Information from scientists from the different 
department is required in the process, e. g., expertise in molecular 
biology, physiology, biochemistry, analytical and medicinal 
chemistry, crystallography, pharmacology, and even more distant 
areas such as information science and robotics [1]. Preclinical and 
clinical investigations are conducted slow, upscale and requires 
about 800 million USD to 1 billion USD in about 15 y. various 
software’s help to predict the interactions, toxicities, thereby 
accurately defining the success of a novel compound [2]. The in silico 
experiments in research and development (RandD) are used to speed 
up the development process of the solid dosage form and to replace 
the pricey laboratory experiments [3]. Robots are used in filling, 
inspection, packaging and for producing personalized medicines [4]. 
Digital social media provides a direct interaction of customers with the 
marketers thereby upgrading the marketing strategies [5]. Electronic 
prescription, paperless technology is received at the pharmacy by the 
patients, providing better patient compliance [6].  
Selected reference articles for this review were taken by using 
different keywords like Automation and Digitalization in 
pharmaceuticals, Computer used in pharmaceuticals, Software used 
in pharmaceuticals including drug discovery to drug development 
and drug filing electronically, between 1990-2017 from various 
sources like Google Scholar, PubMed, and Science Direct.  
Prediscovery or target discovery 
Prediscovery is the process of understanding the disease and 
choosing a valid target molecule. 
On the basis of studies associated with biological mutations and 
disease states pharmaceutical researchers formulate hypotheses 
about the mechanism of actions involved they study how genes have 
changed, how these changes affect the proteins encoded by the 
genes, how these proteins interact with each other in living cells, 
how the affected cells change the specific tissue they are in, and how 
all these processes combine to affect the patient followed by 
selecting a biological target [7]. 
Drug discovery 
Finding promising leads (an organic or other drug molecules that 
may act on the target to alter the disease course) for a drug 
candidate. A set of possibilities is embellished with the headway in 
biotechnology, where scientists develop living systems genetically to 
produce disease-fighting biological molecules. A variety of drug 
source is provided by combinatorial chemistry, it enables the quick 
generation of molecules to exacerbate the chemical diversity if the 
known molecule libraries. The easiest way for screening the already 
existing libraries to find the compounds that can modify the chosen 
target without affecting any off-target molecules is the high 
throughput screening [8]. Also, the X-ray crystallography and 
nuclear magnetic resonance (NMR) helps to identify the structure of 
the molecule. After many iterations, the final compound becomes a 
drug candidate [8]. 
In the drug designing, the in silico analysis has been performed using 
Windows operating system which is implemented with Maestro 
Software package. This package was provided by Schrodinger, 
implementing the desired modules Glide, Phase, LigPrep and Quik 
prop [11, 12]. 
Preclinical trials and clinical trials 
Randomization is applied by the software to remove bias and to plan 
study design. In the preclinical trials softwares like electronic data 
capture, remote data capture and electronic case report form (eCRF) 
are used to store the data. For the clinical data management and 
statistical analysis of the data softwares like eClinical and Oracle 
clinical, clinical conductor clinical trial management system (CTMS) 
(by Bio-Optronics), Clindex, Ascend (by Biopharm) are being used 
effectively. They aid in the planning, data collections, data accession, 
exchange, and for the execution, management, analysis, and 
reporting of the trial is carried out electronically [13-16]. The 
electronic data capture (EDC) provides an ease of entering the 
information directly into the software over an internet connection 
[17-21].  
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Big data management (BDM) technologies help in solving the data 
storing issues and support specialized tools and facilities that can 
be used for normalizing and harmonizing data, used by advanced 
analytics. With big data mangement (BDM), the medical records 




Fig. 1: High throughput screening technique to screen the existing libraries of compounds [9] 
 
 
Fig. 2: Nuclear magnetic resonance (NMR) spectrometer to identify the structure of the molecule [10] 
 
 
Fig. 3: Electronic data capture (EDC) during clinical trials [25] 
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Filing of new drug application 
The regulatory submissions in the electronic format are 
accredited by the Food and Drug Administration (FDA) to the 
Center for Drug Evaluation and Research (CDER) and the Center 
for Biologics Evaluation and Research (CBER) [26]. Submissions 
are carried out using the electronic common technical document 
(eCTD). After the information is submitted to the Food and Drug 
Administration (FDA) and the attainment of the receipt, the 
report is submitted electronically through the electronic 
submission gateway (ESG) [26]. 
Research and development 
The in silico experiments are carried out for the research and 
development. For the virtual research and development (e-RandD) 
the in silico experiments are performed using hardware and 
software package of the formulation-computer aided design (F-
CAD)[27,28]. Another science used in the research and development 
(RandD) is Robotics, the technology of robots that possess the 
electro-mechanical system [29]. 
The formulation-computer aided design (F-CAD) is designed by the 
software modules which is based on the concept of cellular 
automata to calculate dissolution profiles of the drug substance as a 
function of the composition and of the physicochemical properties of 
the components in a formulation (solubility, swellability, effect of 
the particle size distribution of the drug substance and the 
excipients, etc.) [30, 31]. 
3-Dimensional (3D) printing technology 
A unique prototyping technology the three-dimensional technology 
can fabricate solid dosage forms with different densities and 
diffusivities, complex internal geometrics, multiple drugs, and 
excipients. It uses computer aided drafting (CAD) technology and 
programming to produce a 3-Dimensional (3D) object by layering 
material onto a substrate [32]. 
 
 
Fig. 4: Formulation-computer aided design (F-CAD) software modules: the semi-filled circles indicate that this module has been 
complemented with discrete element methods [30] 
 
Table 1: Types of printers in 3D printing technology 
Printing technology  Dosage forms Model drug used Reference 
3D Powder direct printing technology Microporous bioceramics Tetracyclin, Vancomycin [33] 
Fused filament 3D printing Tablets Flouroscene [34] 
Piezoelectric inkjet printer Microparticles Paclitaxel [35] 
Microdrop inkjet printer Nanosuspension Folic acid [36] 
Stereolithography printer Anti-acne patch Salicylic acid [37] 
 
 
Fig. 5: Schematics of a) Microfab inkjet printer and b) dispenser, c) micro-drop generation [38] 
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Production and manufacturing 
Manufacturing is a tool of the Pharmaceutical Industry wherein the 
production and manufacturing of the drug product are made out of 
materials using machines or robots. With the development of the 
Automation processes in the industry, the modern contemporary 
automation applied could be fixed or hard automation, flexible 
automation, and programmable automation. The computer 
integrated manufacturing (CIM) and computer aided manufacturing 
(CAM) systems are applied to product development and 
manufacturing activities. These advanced manufacturing systems 
include three types of manufacturing:  
1. Intelligent manufacturing 
2. Virtual manufacturing 
3. Internet controlled manufacturing [39] 
Robots for producing personalized medicines 
The biopharmaceutical partnered companies Invetech and Argos 
Therapeutics developed an automated manufacturing system based 
on Argos’ Arcelis Technology for personalized immunotherapy, 
which uses two, five-axis robotic arms to produce messenger 
Ribonucleic acid (mRNA) from a patient’s tumor used as the antigen 
for loading into the dendritic cells produced in the cellular 
processing equipment. The cellular equipment uses automation to 
manipulate the white blood cells throughout the manufacturing 
process to control their development and maturation into dendritic 
cells. These cells express the desired antigens, which when delivered 
to a patient, will trigger the patient’s immune system to produce 
killer T-cells that will target the metastatic tumors [40]. 
  
 
Fig. 6: Invetech using argos’ arcelis technology for production of patient specific immunotherapies [41] 
 
Paperless manufacturing executing system 
The paperless manufacturing in actual terms is the application of 
software-based electronic systems to monitor and enforce 
manufacturing production processes while capturing all information 
associated with production records. Higher level systems such as 
ERF integrate Paperless systems to get an account of material 
information and orders to manage on the plant floor. There are 
many advantages of this system over the paper-based manual 
systems. The former cater the error-proofing and real-time visibility 
necessary to produce consistent product quality, also dramatically 
expedite the final review and release time by waiving the need for 
manufacturing review [42]. 
Digitalization in quality control and quality assurance 
Considering quality control and assurance, quality control at its core 
is a reactive process, the premarket checks and inspections assure 
pharmaceutical manufacturers of the standard of the product or 
drug [43]. 
 
Table 2: Quality control vs quality assurance [43] 
Quality control Quality assurance 
Product Process 
Reactive Proactive 
 Corrective tool Preventive tool 
Completed by experts Implemented by managers 
Ensures and checks Develops and defines 
Failure detection  Failure prevention 
Identify and correct defects Prevents defects 
Identification through inspections and peer review Prevention with statistical and managerial tools 
 
Pharmaceutical quality control is generally referred by the 
International Conference on Harmonization (ICH) Q10 model which 
is based on International Organization for Standardization (ISO) 
quality concepts, including Good manufacturing practices (GMP) and 
complements International Conference on Harmonization (ICH) “Q8 
Pharmaceutical development” and International Conference on 
Harmonization (ICH) “Q9 Quality Risk Management”. 
International Conference on Harmonization (ICH) Q10 has three 
main objectives:  
• Achieve product realization. 
• Establish and maintain a state of control. 
• Facilitate continual improvement [44]. 
 Quality risk management 
It provides a proactive approach in the identification, scientific 
evaluation and control potential risks to quality. It facilitates 
continual improvement of process performance and product quality 
throughout the product lifecycle [44]. 
 Quality by design 
It is a quality system to manage the product’s lifecycle. It is a 
multifunctional exercise intended to increase process and product 
understanding and thereby decrease patient’s risk. Quality by 
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Design (QbD) is a process defined by documentation requirements 
[45].  
Primary Quality by Design (QbD) documents:  
 Risk assessment report(s) 
 Quality target product profile 
 Control strategy summary 
 PPQ report(s) 
 Continued process verification (CPV) Reports [45] 
 Quality by design (QbD) and new process development 
The goal of process development is the creation of a process control 
strategy. The Quality by design (QbD) process is iterative can have 
multiple feedback modes [45]. 
The outcome of Quality by design (QbD) is a well-designed and 
understood the quality product that consistently delivers the 
continuous performance [45]. 
 
 
Fig. 7: Quality by design (QbD) and new process development [45] 
 
This approach has been used to get method operable design region 
(MODR) for the development of spectrophotometric and 
fluorometric methods for the estimation of Darunavir, also to 
advance product and process quality, particularly in automotive 
industry [46-50].  
 Process analytical technology (PAT) 
Process analytical technology (PAT) is a key element of the 
“Pharmaceutical Current Good Manufacturing Practices (CGMPs) for 
the 21st Century-a Risk-Based Approach” initiative announced by 
the FDA in August 2002 to improve and modernize pharmaceutical 
manufacturing. Process analytical technologies (PAT) is used to 
provide and inform the timely analysis of critical quality parameters 
with the end goal of improving final product quality as well as 
reducing manufacturing costs, thereby significantly benefiting the 
Pharmaceutical Industry in the manufacturing area. Process 
analytical technologies (PAT) involves the use of raw material 
properties, process monitoring, manufacturing parameters and 
chemometric techniques to produce finished products of acceptable 
quality and purity [51]. 
 
 
Fig. 8: Elements of quality by design (QbD) [52] 
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Packaging and labeling 
The pathway of Packaging uses different types of machinery for 
cartooning, wrapping, labeling, shrinking, sealing, case and tray 
forming, capping, cooling and drying, feeding, palletizing, picking 
and placing (robotic systems), cleaning and sterilizing, in addition to 
inspection and detecting machines. 
There are different techniques involved in packaging. Modified 
atmosphere packaging (MAP) is a technique employed to artificially 
reduce oxygen level and inflate carbon-di-oxide level. Smart 
packaging is an advanced packaging pertinent to use of intelligent 
sensors. Nanotechnology-based sensors for packaging are used for 
pathogen and contaminant detection and tracking [53].  
Anti-Counterfeit Technology is enforced to combat counterfeiting of 
the drug products [54, 55].  
Anti-Counterfeit Technologies can be used in three ways:  
1. Tamper-Evident/tamper-resistant packing: This type of 
packaging provides an indicator or barrier to entry which, if 
breached or missing show visible or audible evidence to consumers 
that tampering has ensued. Eg. Film wrappers, shrinkable seals and 
bands, breakable caps, tape seals, blister packs, etc [56].  
2. Product authentication: Authentication features can be 
embedded either on the dose or in the packaging of the medicines 
[57].  
3. Track and Trace Technology: Assigns a unique identity to each 
stock unit in the process of manufacture which is continued via the 
supply chain till its consumption. Information is attached in the form 
of a unique pack coding, enabling access to the same information on 
a secure database [57]. 
 
 
Fig. 9: Smart packaging using track and trace technolog [58] 
 
Techniques such as Mass Serialization and Data Carriers (RFID and 
Barcodes) are also helpful in Packaging and Labeling  
 Radio frequency identification (RFID) 
Radio frequency identification (RFID) is an automated data 
collection technology that utilizes radio-frequency waves to transfer 
data or information between a reader and a movable item to identify 
categorize and track. It provides unique identification and backend 
integration for accessing a wide range of applications [59]. 
Sales and marketing  
The tedious process is the paper-based process that is costly per 
batch, inefficiency, and risk in the form of human errors. To change 
the game, Electronic batch recording has replaced the old method of 
paper documentation with a more agiler software-driven System to 
manage workflows and recordkeeping for everything from recipe 
creation to batch qualification [60].  
This is used to speed up the review time for batch documentation, 
retrieve batch protocols, and eliminate the need to pass records 
physically between stations [60]. Online professional and patient 
communities have developed to adapt increased usage of mobile, 
social media, as well as online information by patients, healthcare 
professionals (HCP), key opinion leaders (KOL) and the larger 
medical fraternity, have instigated pharmaceutical companies to 




Fig. 10: Portraiture of radio-frequency identifier technology [59] 
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A continuous interaction between customers and the marketers is 
provided by the digital media. The pharmaceutical companies are 
adopting new online media, namely electronic detailing (e-Detailing) 
to promote the medicines to physicians. The modest attempts made 
by this inclination are blooming of Apps by the pharmaceutical 
companies. In the pharmaceutical companies, Johnson and Johnson 
was one of the first to launch a YouTube channel. Offer to online 
order special medicines, to promote e-commerce and digital 
marketing was provided by Quantum Pharmaceuticals and The 
Specials Lab, North East based pharmaceutical companies [61]. 
Types of digital marketing used are 
1. Search engine optimization (SEO). 
2. Social Media Marketing. 
3. Pay Per Click Ads. 
4. E-Mail Newsletters [61]. 
Dispensing pharmacy 
Techniques are developed for the ease of the dispensing which likely 
includes electronic prescription (eRx) and electronic repeat design 
(eRD). In electronic prescription (eRx), the pharmacies directly 
receive the prescriptions from the doctors, a paperless prescription. 
Electronic prescribing is an aid in the safety as it provides a secure 
access the patient’s prescription history to the doctors and helps 
them prescribe the drugs that will not interact with other 
prescription drugs that the patient might take.  
It provides serenity to the pharmacist by the less chance of 
accidentally giving the wrong drug or dose which might be 
caused due to the handwritten prescriptions.  
Electronic prescription (eRx) helps the doctors to check the 
insurance covers the patient in order to prescribe a covered 
drug that the patient could afford [64]. 
Electronic repeat design (eRD) is a technique that allows the 
prescriber to authorize and issue a batch of repeatable prescriptions 
for up to 12 mo with one digital signature. eRD stores all issues of 
the electronic repeat design (eRD) prescriptions securely on the 
National Health Service (NHS) Spine and delivers them to the 
patient’s nominated dispenser at the intervals set by the prescriber. 
The prescriber retains the ability to change or cancel the 
prescription at any time [65]. 
 
 
Fig. 11: Electronic batch recording (EBR) software [62] 
 
 
Fig. 12: Digital customer/patient [63] 
 
 
Fig. 13: e-prescription (eRx) [66] 
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Digital strategies for monitoring drug administration 
Drug Monitoring is an important factor in the healthcare of the 
patients. The electronic drug monitoring systems (eDMS) are used to 
evaluate the time nurses spend on clinical documentation. It is 
carried out for the safety concerns, high potential for error and can 
be assisted with the use of information and communication 
technology (ICT). The electronic drug monitoring systems (eDMS) 
are a combination of both manual and electronic systems [67-69]. 
The prescription drug monitoring programs (PDMPs) is a statewide 
electronic database that tracks all the controlled substance 
prescriptions. There is an access to the authorized users to the 
prescription data, such as medications dispensed and doses. The 
programs subject to improving the way, opioids are prescribed will 
ensure patients have access to safer, more effective chronic pain 
treatment while reducing opioid misuse, abuse, and overdose [70].  
 Drug monitoring and healthcare applications 
In the market of applications, there are free and premium medical 
apps, some that allow a better understanding about pharmaceuticals 
while others work to diagnose the symptoms and help to prepare for 
an unforeseen medical emergency [71]. 
• Micromedex: Reference app with features such as proper drug 
dosage and medicine recommendations. 
• Johns Hopkins ABX guide allows you to search for information 
on medications and treatments regarding various illnesses. 
• The Red Cross’ official first aid app provides simple step-by-step 
instructions to guide for everyday first aid scenarios, whether to 
consider asthma attacks or broken bones. 
• Mychart: Allow you to access your medical records on your 
phone at any time. 
• Epocrates: It not only does the robust offering supply basic 
information regarding the side effects and dosage amounts of 
various prescription drugs but also provide the access to contact 
their manufacturer directly. 
• Doctor on demand: This convenient app aids, to instantly connect 
with the licensed professionals via video chats and audio calls, thus 
granting an ease of access to medical advice and prescriptions based on 
particular symptoms without stepping out of the door. 
• Medscape medpulse is a news aggregator designed for anything 
and everything related to the world of medicine. The app provides 
you with an onslaught of articles, written specifically for physicians, 
students, and healthcare professionals. 
• WebMD allows people to set medication schedules, create a process 
with which they can use to meet a personal health goal, and check for 
local physicians and pharmacies which patients may be unaware [71]. 
 
 
Fig. 14: Drug monitoring and healthcare applications [72] 
 
CONCLUSION 
The digitalization and automation process in the pharmaceutical 
industry is rapidly growing, many devices, robots, and softwares have 
been used. Advanced analytics, sensors, and the automation of 
complex decisions are adept at delivering a step change in the 
efficiency, speed, quality, and responsiveness of processes in every 
industry. These are employed for the development of the process and 
to obtain a better drug product with enhanced efficacy. Maximum 
advancement in the drug distribution and dispensing of the 
pharmaceutical product is associated with progress in digitalization. 
However, even after these many advancements in the digitalization of 
the pharmaceuticals still, there is a scope for innovation and 
advancement in the development of pharmaceuticals. 
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